
Gastric Cancer Therapy Global Market Report 2025
Description
Gastric Cancer Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on gastric cancer therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies. Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes. Create regional and country strategies on the basis of local data and analysis. Identify growth segments for investment. Outperform competitors using forecast data and the drivers and trends shaping the market. Understand customers based on the latest market shares. Benchmark performance against key competitors. Suitable for supporting your internal and external presentations with reliable high quality data and analysis Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis. All data from the report will also be delivered in an excel dashboard format.
Description:
Where is the largest and fastest growing market for gastric cancer therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastric cancer therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development. The forecasts are made after considering the major factors currently impacting the market. These include: The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates. Market segmentations break down the market into sub markets. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified. The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Therapy Type: Chemotherapy; Targeted Therapy; Immunotherapy; Radiation Therapy; Surgery
2) By Drug Class: Cytotoxic Agents; Monoclonal Antibodies; Tyrosine Kinase Inhibitors; Checkpoint Inhibitors; Miscellaneous Agents
3) By Administration Route: Oral; Intravenous; Intramuscular; Subcutaneous
4) By Stage of Disease: Early Stage; Locally Advanced Stage; Metastatic Stage
5) By End User: Hospitals; Oncology Clinics; Ambulatory Surgical Centers; Research Institutions; Home Care Settings
Subsegments:
1) By Chemotherapy: Neoadjuvant Chemotherapy (NAC); Adjuvant Chemotherapy (AC); Palliative Chemotherapy (PC); Combination Chemotherapy; Monotherapy
2) By Targeted Therapy: Human Epidermal Growth Factor Receptor 2 (HER2) Targeted Therapy; Vascular Endothelial Growth Factor (VEGF) Inhibitors; Fibroblast Growth Factor Receptor (FGFR) Inhibitors; Mesenchymal-Epithelial Transition (MET) Inhibitors; Claudin 18 Isoform 2 Inhibitors
3) By Immunotherapy: Immune Checkpoint Inhibitors; Cancer Vaccines; Adoptive Cell Transfer; Cytokine Therapy; Combination Immunotherapy
4) By Radiation Therapy: External Beam Radiation Therapy (EBRT); Intensity-Modulated Radiation Therapy (IMRT); Three-Dimensional Conformal Radiation Therapy (3D-CRT); Brachytherapy
5) By Surgery: Endoscopic Mucosal Resection (EMR); Endoscopic Submucosal Dissection (ESD); Subtotal Gastrectomy; Total Gastrectomy; Lymphadenectomy
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca PLC; Novartis AG; GSK plc; Eli Lilly and Company; Amgen Inc.; Teva Pharmaceutical Industries Ltd.; Otsuka Holdings Co. Ltd.; Astellas Pharma Inc.; Jiangsu Hengrui Pharmaceuticals Co. Ltd.; BeiGene Ltd.; Celltrion Healthcare Co. Ltd.; Hutchison MediPharma Limited; Shanghai Henlius Biotech Inc.; Imugene Limited; LintonPharm Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on gastric cancer therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Description:
Where is the largest and fastest growing market for gastric cancer therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastric cancer therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Scope
Markets Covered:1) By Therapy Type: Chemotherapy; Targeted Therapy; Immunotherapy; Radiation Therapy; Surgery
2) By Drug Class: Cytotoxic Agents; Monoclonal Antibodies; Tyrosine Kinase Inhibitors; Checkpoint Inhibitors; Miscellaneous Agents
3) By Administration Route: Oral; Intravenous; Intramuscular; Subcutaneous
4) By Stage of Disease: Early Stage; Locally Advanced Stage; Metastatic Stage
5) By End User: Hospitals; Oncology Clinics; Ambulatory Surgical Centers; Research Institutions; Home Care Settings
Subsegments:
1) By Chemotherapy: Neoadjuvant Chemotherapy (NAC); Adjuvant Chemotherapy (AC); Palliative Chemotherapy (PC); Combination Chemotherapy; Monotherapy
2) By Targeted Therapy: Human Epidermal Growth Factor Receptor 2 (HER2) Targeted Therapy; Vascular Endothelial Growth Factor (VEGF) Inhibitors; Fibroblast Growth Factor Receptor (FGFR) Inhibitors; Mesenchymal-Epithelial Transition (MET) Inhibitors; Claudin 18 Isoform 2 Inhibitors
3) By Immunotherapy: Immune Checkpoint Inhibitors; Cancer Vaccines; Adoptive Cell Transfer; Cytokine Therapy; Combination Immunotherapy
4) By Radiation Therapy: External Beam Radiation Therapy (EBRT); Intensity-Modulated Radiation Therapy (IMRT); Three-Dimensional Conformal Radiation Therapy (3D-CRT); Brachytherapy
5) By Surgery: Endoscopic Mucosal Resection (EMR); Endoscopic Submucosal Dissection (ESD); Subtotal Gastrectomy; Total Gastrectomy; Lymphadenectomy
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca PLC; Novartis AG; GSK plc; Eli Lilly and Company; Amgen Inc.; Teva Pharmaceutical Industries Ltd.; Otsuka Holdings Co. Ltd.; Astellas Pharma Inc.; Jiangsu Hengrui Pharmaceuticals Co. Ltd.; BeiGene Ltd.; Celltrion Healthcare Co. Ltd.; Hutchison MediPharma Limited; Shanghai Henlius Biotech Inc.; Imugene Limited; LintonPharm Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
250 Pages
- 1. Executive Summary
- 2. Gastric Cancer Therapy Market Characteristics
- 3. Gastric Cancer Therapy Market Trends And Strategies
- 4. Gastric Cancer Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 5. Global Gastric Cancer Therapy Growth Analysis And Strategic Analysis Framework
- 5.1. Global Gastric Cancer Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Gastric Cancer Therapy Market Growth Rate Analysis
- 5.4. Global Gastric Cancer Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Gastric Cancer Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Gastric Cancer Therapy Total Addressable Market (TAM)
- 6. Gastric Cancer Therapy Market Segmentation
- 6.1. Global Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Radiation Therapy
- Surgery
- 6.2. Global Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cytotoxic Agents
- Monoclonal Antibodies
- Tyrosine Kinase Inhibitors
- Checkpoint Inhibitors
- Miscellaneous Agents
- 6.3. Global Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Intravenous
- Intramuscular
- Subcutaneous
- 6.4. Global Gastric Cancer Therapy Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Early Stage
- Locally Advanced Stage
- Metastatic Stage
- 6.5. Global Gastric Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Oncology Clinics
- Ambulatory Surgical Centers
- Research Institutions
- Home Care Settings
- 6.6. Global Gastric Cancer Therapy Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Neoadjuvant Chemotherapy (NAC)
- Adjuvant Chemotherapy (AC)
- Palliative Chemotherapy (PC)
- Combination Chemotherapy
- Monotherapy
- 6.7. Global Gastric Cancer Therapy Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Human Epidermal Growth Factor Receptor 2 (HER2) Targeted Therapy
- Vascular Endothelial Growth Factor (VEGF) Inhibitors
- Fibroblast Growth Factor Receptor (FGFR) Inhibitors
- Mesenchymal-Epithelial Transition (MET) Inhibitors
- Claudin 18 Isoform 2 Inhibitors
- 6.8. Global Gastric Cancer Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Immune Checkpoint Inhibitors
- Cancer Vaccines
- Adoptive Cell Transfer
- Cytokine Therapy
- Combination Immunotherapy
- 6.9. Global Gastric Cancer Therapy Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- External Beam Radiation Therapy (EBRT)
- Intensity-Modulated Radiation Therapy (IMRT)
- Three-Dimensional Conformal Radiation Therapy (3D-CRT)
- Brachytherapy
- 6.10. Global Gastric Cancer Therapy Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Endoscopic Mucosal Resection (EMR)
- Endoscopic Submucosal Dissection (ESD)
- Subtotal Gastrectomy
- Total Gastrectomy
- Lymphadenectomy
- 7. Gastric Cancer Therapy Market Regional And Country Analysis
- 7.1. Global Gastric Cancer Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Gastric Cancer Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Gastric Cancer Therapy Market
- 8.1. Asia-Pacific Gastric Cancer Therapy Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Gastric Cancer Therapy Market
- 9.1. China Gastric Cancer Therapy Market Overview
- 9.2. China Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Gastric Cancer Therapy Market
- 10.1. India Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Gastric Cancer Therapy Market
- 11.1. Japan Gastric Cancer Therapy Market Overview
- 11.2. Japan Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Gastric Cancer Therapy Market
- 12.1. Australia Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Gastric Cancer Therapy Market
- 13.1. Indonesia Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Gastric Cancer Therapy Market
- 14.1. South Korea Gastric Cancer Therapy Market Overview
- 14.2. South Korea Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Gastric Cancer Therapy Market
- 15.1. Western Europe Gastric Cancer Therapy Market Overview
- 15.2. Western Europe Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Gastric Cancer Therapy Market
- 16.1. UK Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Gastric Cancer Therapy Market
- 17.1. Germany Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Gastric Cancer Therapy Market
- 18.1. France Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Gastric Cancer Therapy Market
- 19.1. Italy Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Gastric Cancer Therapy Market
- 20.1. Spain Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Gastric Cancer Therapy Market
- 21.1. Eastern Europe Gastric Cancer Therapy Market Overview
- 21.2. Eastern Europe Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Gastric Cancer Therapy Market
- 22.1. Russia Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Gastric Cancer Therapy Market
- 23.1. North America Gastric Cancer Therapy Market Overview
- 23.2. North America Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Gastric Cancer Therapy Market
- 24.1. USA Gastric Cancer Therapy Market Overview
- 24.2. USA Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Gastric Cancer Therapy Market
- 25.1. Canada Gastric Cancer Therapy Market Overview
- 25.2. Canada Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Gastric Cancer Therapy Market
- 26.1. South America Gastric Cancer Therapy Market Overview
- 26.2. South America Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Gastric Cancer Therapy Market
- 27.1. Brazil Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Gastric Cancer Therapy Market
- 28.1. Middle East Gastric Cancer Therapy Market Overview
- 28.2. Middle East Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Gastric Cancer Therapy Market
- 29.1. Africa Gastric Cancer Therapy Market Overview
- 29.2. Africa Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Gastric Cancer Therapy Market Competitive Landscape And Company Profiles
- 30.1. Gastric Cancer Therapy Market Competitive Landscape
- 30.2. Gastric Cancer Therapy Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 31. Gastric Cancer Therapy Market Other Major And Innovative Companies
- 31.1. AstraZeneca PLC
- 31.2. Novartis AG
- 31.3. GSK plc
- 31.4. Eli Lilly and Company
- 31.5. Amgen Inc.
- 31.6. Teva Pharmaceutical Industries Ltd.
- 31.7. Otsuka Holdings Co. Ltd.
- 31.8. Astellas Pharma Inc.
- 31.9. Jiangsu Hengrui Pharmaceuticals Co. Ltd.
- 31.10. BeiGene Ltd.
- 31.11. Celltrion Healthcare Co. Ltd.
- 31.12. Hutchison MediPharma Limited
- 31.13. Shanghai Henlius Biotech Inc.
- 31.14. Imugene Limited
- 31.15. LintonPharm Co. Ltd.
- 32. Global Gastric Cancer Therapy Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Gastric Cancer Therapy Market
- 34. Recent Developments In The Gastric Cancer Therapy Market
- 35. Gastric Cancer Therapy Market High Potential Countries, Segments and Strategies
- 35.1 Gastric Cancer Therapy Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Gastric Cancer Therapy Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Gastric Cancer Therapy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.